title: [Treatment with anticoagulants in glomerulonephritis (author's transl)].
abstract: Four patients with different forms of glomerulonephritis were treated with the anticoagulant heparin (Liquemin) or phenprocoumon (Marcumar). Following the results in these cases and the experiences of other research groups, which have been published in the last few years, we have tried to lay down a scheme for treatment with anticoagulants in glomerulonephritis. Such a treatment is recommended in peracute or rapid progressing glomerulonephritis, in forms of the disease of which is  known that they have a poor prognosis, and in situations in which the risk of simultaneous thromboembolic complications as a result of a nephrotic syndrome represents a further argument for the use of anticoagulants.
mesh_terms: D015110:4-Hydroxycoumarins / Q000627:therapeutic use*; D058186:Acute Kidney Injury / Q000209:etiology; D000328:Adult; D003404:Creatinine / Q000097:blood; D005260:Female; D005921:Glomerulonephritis / Q000150:complications / Q000188:drug therapy*; D006417:Hematuria / Q000209:etiology; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009404:Nephrotic Syndrome / Q000209:etiology; D010644:Phenprocoumon / Q000627:therapeutic use*; D011379:Prognosis; D011507:Proteinuria / Q000209:etiology
chemical_list: D015110:4-Hydroxycoumarins; D006493:Heparin; D003404:Creatinine; D010644:Phenprocoumon
vernacular_title: Antikoagulantienbehandlung bei Glomerulonephritis.